Alexandria Real Estate Equities (NYSE:ARE) (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.
Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe. Key markets include Boston/Cambridge, the San Francisco Bay Area, San Diego, New York City, Seattle, Maryland’s I-270 corridor, Chicago, Research Triangle Park and London. Through strategic development and acquisition, the company has established long-term relationships with emerging and established life science companies, academic institutions and government agencies.
Over the years, Alexandria has built a reputation for creating integrated communities that blend laboratory facilities with office space, amenity offerings and shared services. These environments are intended to foster collaboration among scientists, entrepreneurs and corporate partners. The company’s leadership has guided its growth from a niche REIT into one of the largest owners and operators of life science real estate, with a management team led by Founder and Executive Chairman Joel S. Marcus and President & CEO Michael J. Wilson.
Alexandria’s business model emphasizes long-term partnerships with tenants and strategic investment in infrastructure that anticipates industry trends, such as advanced therapy manufacturing and data-driven research. The company also pursues sustainability initiatives and smart-building technologies to enhance energy efficiency and reduce environmental impact across its campuses.
